Stanford researchers have created a CRISPR-based technology to target RNA in neurons, enabling repair processes for genetic diseases. The method addresses key challenges in Cas9 delivery and DNA repair. It reveals unique genome editing rules in neurons, paving the way for targeted therapies.

Researchers have developed a pill that stimulates brain regeneration for stroke recovery by promoting neurogenesis and repairing damage. Tested in preclinical models, the drug replicates rehabilitation effects without extensive therapy. This innovation offers new hope for stroke patients worldwide.

New human studies on transcranial focused ultrasound (tFUS) demonstrated its ability to alter perception, mood, and decision-making, with expansions reported on September 9, 2025.

Scientists at Stanford University have discovered that hyperactivity in the brain's reticular thalamic nucleus may cause autism-like behaviors in mice. By suppressing this overactivity with drugs or neuromodulation, symptoms were reversed in mouse models. This finding suggests potential new therapeutic approaches overlapping with epilepsy treatments.